Chang V T, Hwang S S, Feuerman M, Kasimis B S, Thaler H T
University of Medicine and Dentistry of New Jersey, New Jersey Medical School, Section Hematology/Oncology, VA New Jersey Health Care System at East Orange, 07018, USA.
Cancer. 2000 Sep 1;89(5):1162-71. doi: 10.1002/1097-0142(20000901)89:5<1162::aid-cncr26>3.0.co;2-y.
The Memorial Symptom Assessment Scale Short Form (MSAS-SF), an abbreviated version of the Memorial Symptom Assessment Scale, measures each of 32 symptoms with respect to distress or frequency alone. A physical symptom subscale (PHYS), psychologic symptom subscale (PSYCH), and global distress index (GDI) can be derived from the Short Form. We validated the MSAS-SF in a population of cancer patients.
Two hundred ninety-nine cancer patients examined at the Section of Hematology/Oncology completed the MSAS-SF and the Functional Assessment Cancer Therapy (FACT-G). The Karnofsky performance status (KPS), extent of disease (EOD), and demographic data were assessed. The Cronbach alpha coefficient was used to assess internal reliability. MSAS-SF subscales were assessed against subscales of the FACT-G, the KPS, and EOD to determine criterion validity. Test-retest analysis was performed at 1 day and at 1 week.
The Cronbach alpha coefficients for the MSAS-SF subscales ranged from 0.76 to 0.87. The MSAS-SF subscales showed convergent validity with FACT subscales. Correlation coefficients were -0.74 (P < 0.001) for the PHYS and FACT-G physical well-being subscales, -0.68 (P < 0.001) for the PSYCH and FACT emotional well-being subscales, and -0.70 (P < 0.001) for GDI and FACT summary of quality-of-life subscales. The MSAS-SF subscales demonstrated convergent validity with performance status, inpatient status, and extent of disease. The test-retest correlation coefficients for the MSAS-SF subscales ranged from 0.86 to 0.94 at 1 day and from 0.40 to 0.84 for the 1 week group.
The MSAS-SF is a valid and easy to use instrument for symptom assessment.
纪念症状评估量表简表（MSAS-SF）是纪念症状评估量表的缩写版本，仅针对痛苦程度或频率对32种症状进行逐一测量。可从该简表得出一个身体症状子量表（PHYS）、心理症状子量表（PSYCH）和总体痛苦指数（GDI）。我们在癌症患者群体中对MSAS-SF进行了验证。
在血液学/肿瘤学部接受检查的299名癌症患者完成了MSAS-SF和癌症治疗功能评估量表（FACT-G）。评估了卡诺夫斯基功能状态（KPS）、疾病范围（EOD）和人口统计学数据。使用克朗巴哈α系数评估内部信度。将MSAS-SF子量表与FACT-G子量表、KPS和EOD进行对照评估，以确定效标效度。在1天和1周时进行重测分析。
MSAS-SF子量表的克朗巴哈α系数在0.76至0.87之间。MSAS-SF子量表与FACT子量表显示出收敛效度。PHYS与FACT-G身体状况子量表的相关系数为-0.74（P < 0.001），PSYCH与FACT情感状况子量表的相关系数为-0.68（P < 0.001），GDI与FACT生活质量总结子量表的相关系数为-0.70（P < 0.001）。MSAS-SF子量表与功能状态、住院状态和疾病范围显示出收敛效度。MSAS-SF子量表在1天时的重测相关系数在0.86至0.94之间，1周组的重测相关系数在0.40至0.84之间。
MSAS-SF是一种有效且易于使用的症状评估工具。
